Health care burden of clostridium difficile infection in hospitalized children with inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 19, Issue 4, 2013, Pages 1080-1085

  Pant, Chaitanya ^a   Anderson, Michael P ^b   Deshpande, Abhishek ^c   Altaf, Muhammad A ^a   Grunow, John E ^a   Atreja, Ashish ^d   Sferra, Thomas J ^e  

^a Section of Gastroenterology   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Crohn's disease; Kids' inpatient database; Outcomes; Tridium difficile; Ulcerative colitis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTERIAL COLONIZATION; BLOOD TRANSFUSION; CHILD; CHILD HOSPITALIZATION; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; ENTERITIS; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; INFANT; INTESTINE ANASTOMOSIS; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PARENTERAL NUTRITION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; BACTERIAL STRAIN; CLINICAL OBSERVATION; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DISEASE ASSOCIATION; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL DISCHARGE; HOSPITALIZED CHILD; INCIDENCE; INTESTINE SURGERY; MULTICENTER STUDY; PEDIATRICS; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; CHILD; CHILD, HOSPITALIZED; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INFANT; LENGTH OF STAY; MALE; PROGNOSIS; RISK FACTORS; YOUNG ADULT;

EID: 84876378008     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e3182807563     Document Type: Article

References (32)

1. Khanna S, Pardi DS. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Expert Rev Gastroenterol Hepatol. 2010;4:409-416.
2. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353:2442-2449.
3. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin genevariant strain of Clostridium difficile. N Engl J Med. 2005;353:2433-2441.
4. Muto CA, Pokrywka M, Shutt K, et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol. 2005;26:273-280.
5. McGlone SM, Bailey RR, Zimmer SM, et al. The economic burden of Clostridium difficile. Clin Microbiol Infect. 2012;18:282-289.
6. Zilberberg MD, Tillotson GS, McDonald C. Clostridium difficile infections among hospitalized children, United States, 1997-2006. Emerg Infect Dis. 2010;16:604-609.
7. Nylund CM, Goudie A, Garza JM, et al. Clostridium difficile infection in hospitalized children in the United States. Arch Pediatr Adolesc Med. 2011;165:451-457.
8. Ananthakrishnan AN. Clostridium difficile infection: epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol. 2011;8:17-26.
9. Ananthakrishnan AN, Issa M, Binion DG. Clostridium difficile and inflammatory bowel disease. Gastroenterol Clin North Am. 2009;38: 711-728.
10. Jen MH, Saxena S, Bottle A, et al. Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2011;33:1322-1331.
11. Mezoff E, Mann EA, Hart KW, et al. Clostridium difficile infection and treatment in the pediatric inflammatory bowel disease population. J Pediatr Gastroenterol Nutr. 2011;52:437-441.
12. Pascarella F, Martinelli M, Miele E, et al. Impact of Clostridium difficile infection on pediatric inflammatory bowel disease. J Pediatr. 2009;154: 854-858.
13. Wultanska D, Banaszkiewicz A, Radzikowski A, et al. Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease. Eur J Clin Microbiol Infect Dis. 2010;29:1265-1270.
14. Banaszkiewicz A, Kowalska-Duplaga K, Pytrus T, et al. Clostridium difficile infection in newly diagnosed pediatric patients with inflammatory bowel disease: prevalence and risk factors. Inflamm Bowel Dis. 2012;18: 844-848.
15. Sinh P, Barrett TA, Yun L. Clostridium difficile infection and inflammatory bowel disease: a review. Gastroenterol Res Pract. 2011;2011: 136064.
16. Tremaine WJ. Inflammatory bowel disease and Clostridium difficile-associated diarrhea: a growing problem. Clin Gastroenterol Hepatol. 2007;5:310-311.
17. Markowitz JE, Brown KA, Mamula P, et al. Failure of single-toxin assays to detect Clostridium difficile infection in pediatric inflammatory bowel disease. Am J Gastroenterol. 2001;96:2688-2690.
18. Kelsen JR, Kim J, Latta D, et al. Recurrence rate of Clostridium difficile infection in hospitalized pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:50-55.
19. Pant C, Deshpande A, Anderson MP, et al. Clostridium difficile infection is associated with poor outcomes in end-stage renal disease. J Investig Med. 2012;60:529-532.
20. Bajaj JS, Ananthakrishnan AN, Hafeezullah M, et al. Clostridium difficile is associated with poor outcomes in patients with cirrhosis: A national and tertiary center perspective. Am J Gastroenterol. 2010;105:106-113.
21. Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut. 2008;57:205-210.
22. Rodemann JF, Dubberke ER, Reske KA, et al. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:339-344.
23. Issa M, Ananthakrishnan AN, Binion DG. Clostridium difficile and inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:1432-1442.
24. Jodorkovsky D, Young Y, Abreu MT. Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection. Dig Dis Sci. 2010;55:415-420.
25. Sandora TJ, Fung M, Flaherty K, et al. Epidemiology and risk factors for Clostridium difficile infection in children. Pediatr Infect Dis J. 2011;30: 580-584.
26. Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care. 1998;36:8-27.
27. Werner RM, Asch DA, Polsky D. Racial profiling: the unintended consequences of coronary artery bypass graft report cards. Circulation. 2005; 111:1257-1263.
28. Zhu H, Hill MD. Stroke: the Elixhauser Index for comorbidity adjustment of in-hospital case fatality. Neurology. 2008;71:283-287.
29. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992; 45:613-619.
30. Nguyen GC, Kaplan GG, Harris ML, et al. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103:1443-1450.
31. Kariv R, Navaneethan U, Venkatesh PG, et al. Impact of Clostridium difficile infection in patients with ulcerative colitis. J Crohns Colitis. 2011;5:34-40.
32. Ben-Horin S, Margalit M, Bossuyt P, et al. Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and Clostridium difficile infection. Clin Gastroenterol Hepatol. 2009;7: 981-987.